ReposiTrak shares rose over 10% premarket after its board authorised a new $2 million buyback under a 10B5-1 plan, part of its broader $21 million repurchase program, which still has $7.6 million available. The company said the move supports its capital strategy focused on retiring common shares, redeeming preferred stock, and maintaining its dividend, boosting investor sentiment.